GeNeuro SA Balances Financial Restructuring with Promising MS Treatment Developments
GeNeuro SA navigates financial challenges while advancing its promising clinical developments for autoimmune diseases, including its flagship product GNbAC1 for multiple sclerosis.
2 minutes to read